4.7 Article

Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Machine intelligence in non-invasive endocrine cancer diagnostics

Nicole M. Thomasian et al.

Summary: This article discusses the application of artificial intelligence and machine learning in endocrine cancer diagnosis, exploring how AI can enhance medical imaging analysis, presenting key criteria for evaluating machine learning in medicine, and examining challenges and mitigation strategies in data availability and model interpretability in the context of endocrine cancer diagnosis.

NATURE REVIEWS ENDOCRINOLOGY (2022)

Article Clinical Neurology

Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome

Lukas Andereggen et al.

Summary: This study assessed the influence of IPS drainage patterns on detection of adenoma in patients with Cushing's disease (CD). Results showed that IPS symmetry did not affect the accuracy of predicting tumor location using BIPSS in CD patients, nor did it influence the clinical outcome.

JOURNAL OF NEURORADIOLOGY (2021)

Article Endocrinology & Metabolism

Radiomics With Ensemble Machine Learning Predicts Dopamine Agonist Response in Patients With Prolactinoma

Yae Won Park et al.

Summary: This study aimed to predict the response of prolactinoma patients to dopamine agonists using an ensemble machine learning classifier with MRI images, with the ensemble classifier showing the best performance in the test set.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Medicine, Research & Experimental

The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma

Ingrid M. Zandbergen et al.

Summary: This study aims to compare the effectiveness of early surgery versus dopamine agonist treatment in patients with limited-sized non-invasive prolactinomas, through three randomized controlled trials and an observational cohort study. The primary outcomes include disease remission after 36 months and HRQoL after 12 months.

TRIALS (2021)

Article Multidisciplinary Sciences

Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas

Lukas Andereggen et al.

Summary: In prolactinoma patients, men have a higher risk of bone impairment than women during treatment, with persistent hyperprolactinemia and male sex being independent risk factors for long-term bone damage. Special attention to bone loss in men with prolactinomas is advised in osteoporosis prevention and treatment.

SCIENTIFIC REPORTS (2021)

Article Cardiac & Cardiovascular Systems

Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction

Rohan Khera et al.

Summary: This study aimed to evaluate the role of contemporary machine learning methods in predicting in-hospital death after AMI. The study found that while machine learning models did not significantly improve the prediction of in-hospital mortality after AMI, certain models were able to more accurately classify risk for high-risk individuals.

JAMA CARDIOLOGY (2021)

Article Clinical Neurology

Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort

Lukas Andereggen et al.

Summary: This study found that resection of one-third of the lateral pituitary gland based on IPSS predictions in CD patients without intraoperative adenoma identification resulted in low morbidity and long-term remission in 31% of patients, with some patients experiencing new pituitary hormone deficits. Long-term control of hypercortisolism was achieved in 77% of patients, but additional therapies were needed for 69% of them. Considering the small sample size, the decision to perform lateral one-third-gland resection should be carefully discussed with patients before surgery.

ACTA NEUROCHIRURGICA (2021)

Article Endocrinology & Metabolism

Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study

Yi Fang et al.

Summary: Accurate predictive models for hormonal prognosis in NFPA were lacking. Machine learning models were developed to assess pituitary hormonal outcomes post-surgery, showing significant changes in hormone levels and the effectiveness of ML in predicting outcomes.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Neurosciences

GAMER-MRI in Multiple Sclerosis Identifies the Diffusion-Based Microstructural Measures That Are Most Sensitive to Focal Damage: A Deep-Learning-Based Analysis and Clinico-Biological Validation

Po-Jui Lu et al.

Summary: In the study, a deep learning technique was applied to diffusion imaging data to select the most discriminative diffusion measures for classifying MS lesions and surrounding tissue. By correlating with clinical and biological data, the combination of microstructural measures that best reflect disability and neuroaxonal damage was identified.

FRONTIERS IN NEUROSCIENCE (2021)

Article Endocrinology & Metabolism

First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center

L. Andereggen et al.

Summary: The study retrospectively reviewed patients with prolactinomas Knosp grade <= 1 treated with upfront surgery, and found that for patients with microprolactinomas, first-line surgery resulted in a higher long-term remission rate, while for patients with macroprolactinomas, more of them required long-term dopamine agonist therapy.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Editorial Material Endocrinology & Metabolism

Commentary: Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery

Lukas Andereggen et al.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Oncology

Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors

Pier Paolo Mattogno et al.

Summary: Surgery is shown to have a high cure rate for prolactinomas, especially in female patients with microadenomas. Surgical treatment and female gender are independent positive predictors of a cure at 5 years follow-up, and postoperative serum prolactin levels within 24 hours are crucial for predicting cure.

CANCERS (2021)

Article Endocrinology & Metabolism

Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term

Lukas Andereggen et al.

Summary: In this comparative study on patients with prolactinoma, both transsphenoidal surgery (TSS) and dopamine agonists (DAs) were effective in controlling hyperprolactinemia and hypogonadism in the majority of patients over the long-term. While both treatment modalities led to improvements in BMI and fasting glucose levels, changes in the lipid profile were minimal and independent of the treatment used. The primary predictor for long-term obesity was found to be increased BMI at baseline, rather than the choice of treatment strategy.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated

Lukas Andereggen et al.

Summary: In prolactinoma patients receiving chronic CAB therapy, there was a slight increase in IGF-1 levels at the last follow-up without significant changes. The majority of patients had normal serum IGF-1 levels, and no symptoms of acromegaly were observed, indicating that continuous IGF-1 monitoring may not be necessary in these patients.

ENDOCRINE (2021)

Review Endocrinology & Metabolism

Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis

Amir H. Zamanipoor Najafabadi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery

Grzegorz Zielinski et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Health Care Sciences & Services

Logistic regression was as good as machine learning for predicting major chronic diseases

Simon Nusinovici et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)

Article Endocrinology & Metabolism

Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas

Jose Miguel Hinojosa-Amaya et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Medicine, General & Internal

Machine Learning in Medicine

Alvin Rajkomar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Health Care Sciences & Services

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

Evangelia Christodoulou et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)

Article Medicine, General & Internal

A ten-year follow-up study of treatment outcome of craniopharyngiomas

SWISS MEDICAL WEEKLY (2018)

Editorial Material Health Care Sciences & Services

Validation in prediction research: the waste by data splitting COMMENTARY

Ewout W. Steyerberg

JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)

Article Endocrinology & Metabolism

Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal

Margarida Teixeira et al.

PITUITARY (2017)

Article Multidisciplinary Sciences

Optimal classifier for imbalanced data using Matthews Correlation Coefficient metric

Sabri Boughorbel et al.

PLOS ONE (2017)

Review Clinical Neurology

The 2017 World Health Organization classification of tumors of the pituitary gland: a summary

M. Beatriz S. Lopes

ACTA NEUROPATHOLOGICA (2017)

Article Endocrinology & Metabolism

SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP

Diane Donegan et al.

ENDOCRINE PRACTICE (2017)

Article Endocrinology & Metabolism

Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?

Sema Ciftci Dogansen et al.

PITUITARY (2016)

Article Endocrinology & Metabolism

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience

A. Arduc et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)

Article Endocrinology & Metabolism

Second attempt to withdraw cabergoline in prolactinomas: a pilot study

Ratchaneewan Kwancharoen et al.

PITUITARY (2014)

Editorial Material Medicine, General & Internal

Dopamine Receptor Agonist Drugs and Impulse Control Disorders

Howard D. Weiss et al.

JAMA INTERNAL MEDICINE (2014)

Article Endocrinology & Metabolism

Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients

Vanessa Primeau et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)

Article Endocrinology & Metabolism

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Shlomo Melmed et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Review Endocrinology & Metabolism

Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis

Olaf M. Dekkers et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Endocrinology & Metabolism

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma

Neil Herring et al.

CLINICAL ENDOCRINOLOGY (2009)

Article Endocrinology & Metabolism

Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactinemia

M. Kars et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Biochemistry & Molecular Biology

Super learner

Mark J. van der Laan et al.

STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2007)

Article Endocrinology & Metabolism

Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy

Annamaria Colao et al.

CLINICAL ENDOCRINOLOGY (2007)

Article Medicine, General & Internal

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

Renzo Zanettini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium

Adrian F. Daly et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Article Clinical Neurology

Pituitary disease: Presentation, diagnosis, and management

A Levy

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)

Article Medicine, General & Internal

Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia

A Colao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)